Intec Pharma enrols first patient in phase III trial of AP-CDLD for advanced Parkinson's

Intec Pharma has enrolled the first patient in the US under its phase III clinical trial for Accordion Pill Carbidopa/Levodopa (AP-CDLD) for treatment of patients with advanced Parkinson's disease.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news